Blue Steens in March 2020
Check out my latest monthly review! It summarises Blue Steens’ latest posts and showcases some informative online content that I […]
Glimpse at the complexity of drug pricing
I feel that there is considerable confusion about drug prices amongst industry outsiders. Until I started looking into the topic, […]
My MSc dissertation on healthcare derivatives
In 2019, I graduated with Distinction from the roller-coaster that was my one-year full-time MSc in Finance and Investment Management […]
Who is afraid of … granny?
Thoughts on: Why you shouldn’t fear the gray tsunami, David Rotman, 21 Aug 2019 The above article kept cropping up […]
Paying for patient expertise
Scientists in academic or other institutions use the unique insights patients provide to inform their research. Pharmaceutical companies oftentimes look […]